Quest/Unilab
This article was originally published in The Gray Sheet
Executive Summary
Diagnostic testing services firms complete merger Feb. 26 following an 11-month delay due to Federal Trade Commission concerns that the deal would lead to higher prices for clinical lab service customers in Northern California. A consent order with the agency requires that Quest divest assets worth $4.5 mil. to LabCorp - including leases for 46 patient services centers and four contracts with physician groups in Northern California. The $827 mil. cash and stock purchase of Unilab by Quest was first announced in April 2002 (1"The Gray Sheet" April 8, 2002, p. 19)...
You may also be interested in...
Quest Diagnostics Spends $1.6 Bil. To Expand Presence In California, D.C.
Quest Diagnostics will control 12% of the $3.8 bil. California lab testing market following the acquisition of Unilab Corp. The $1.1 bil. deal was announced April 2, one day after Quest completed its $500 mil. cash acquisition of Amercian Medical Labs (AML)
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.